122 related articles for article (PubMed ID: 32410355)
1. Common cancer biomarkers of breast and ovarian types identified through artificial intelligence.
Pawar S; Liew TO; Stanam A; Lahiri C
Chem Biol Drug Des; 2020 Sep; 96(3):995-1004. PubMed ID: 32410355
[TBL] [Abstract][Full Text] [Related]
2. Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System.
He T; Huang L; Li J; Wang P; Zhang Z
Front Med (Lausanne); 2021; 8():587496. PubMed ID: 34109184
[No Abstract] [Full Text] [Related]
3. InFlo: a novel systems biology framework identifies cAMP-CREB1 axis as a key modulator of platinum resistance in ovarian cancer.
Dimitrova N; Nagaraj AB; Razi A; Singh S; Kamalakaran S; Banerjee N; Joseph P; Mankovich A; Mittal P; DiFeo A; Varadan V
Oncogene; 2017 Apr; 36(17):2472-2482. PubMed ID: 27819677
[TBL] [Abstract][Full Text] [Related]
4. Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers.
Kawakami E; Tabata J; Yanaihara N; Ishikawa T; Koseki K; Iida Y; Saito M; Komazaki H; Shapiro JS; Goto C; Akiyama Y; Saito R; Saito M; Takano H; Yamada K; Okamoto A
Clin Cancer Res; 2019 May; 25(10):3006-3015. PubMed ID: 30979733
[TBL] [Abstract][Full Text] [Related]
5. Identification of molecular biomarkers for ovarian cancer using computational approaches.
Lalremmawia H; Tiwary BK
Carcinogenesis; 2019 Jul; 40(6):742-748. PubMed ID: 30753333
[TBL] [Abstract][Full Text] [Related]
6. Artificial Intelligence in Ovarian Cancer Diagnosis.
Akazawa M; Hashimoto K
Anticancer Res; 2020 Aug; 40(8):4795-4800. PubMed ID: 32727807
[TBL] [Abstract][Full Text] [Related]
7. Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancer.
Fitzgerald J; Higgins D; Mazo Vargas C; Watson W; Mooney C; Rahman A; Aspell N; Connolly A; Aura Gonzalez C; Gallagher W
J Clin Pathol; 2021 Jul; 74(7):429-434. PubMed ID: 34117103
[TBL] [Abstract][Full Text] [Related]
8. CREB1/Lin28/miR-638/VASP Interactive Network Drives the Development of Breast Cancer.
Hu PC; Li K; Tian YH; Pan WT; Wang Y; Xu XL; He YQ; Gao Y; Wei L; Zhang JW
Int J Biol Sci; 2019; 15(12):2733-2749. PubMed ID: 31754343
[TBL] [Abstract][Full Text] [Related]
9. Network motif-based identification of breast cancer susceptibility genes.
Zhang Y; Xuan J; de Los Reyes BG; Clarke R; Ressom HW
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():5696-9. PubMed ID: 19164010
[TBL] [Abstract][Full Text] [Related]
10. MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature.
Gendoo DMA; Zon M; Sandhu V; Manem VSK; Ratanasirigulchai N; Chen GM; Waldron L; Haibe-Kains B
Sci Rep; 2019 Jun; 9(1):8770. PubMed ID: 31217513
[TBL] [Abstract][Full Text] [Related]
11. FGMD: A novel approach for functional gene module detection in cancer.
Jin D; Lee H
PLoS One; 2017; 12(12):e0188900. PubMed ID: 29244808
[TBL] [Abstract][Full Text] [Related]
12. Robust edge-based biomarker discovery improves prediction of breast cancer metastasis.
Adnan N; Lei C; Ruan J
BMC Bioinformatics; 2020 Sep; 21(Suppl 14):359. PubMed ID: 32998692
[TBL] [Abstract][Full Text] [Related]
13. Integrating Artificial and Human Intelligence: A Partnership for Responsible Innovation in Biomedical Engineering and Medicine.
Dzobo K; Adotey S; Thomford NE; Dzobo W
OMICS; 2020 May; 24(5):247-263. PubMed ID: 31313972
[TBL] [Abstract][Full Text] [Related]
14. CA-125 might be good predictive tumor biomarker for earlier detection of serosal metastases including the ovarian metastasis in high-risk invasive lobular breast cancer.
Abduyev Z; Altundag K
J BUON; 2019; 24(4):1735. PubMed ID: 31646834
[No Abstract] [Full Text] [Related]
15. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
16. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.
Liu R; Guo CX; Zhou HH
Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of a protein signature discriminating six common types of adenocarcinoma.
Bloom GC; Eschrich S; Zhou JX; Coppola D; Yeatman TJ
Int J Cancer; 2007 Feb; 120(4):769-75. PubMed ID: 17131332
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer beyond imaging: integration of AI and multiomics biomarkers.
Hatamikia S; Nougaret S; Panico C; Avesani G; Nero C; Boldrini L; Sala E; Woitek R
Eur Radiol Exp; 2023 Sep; 7(1):50. PubMed ID: 37700218
[TBL] [Abstract][Full Text] [Related]
19. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood mononuclear cell derived biomarker detection using eXplainable Artificial Intelligence (XAI) provides better diagnosis of breast cancer.
Kumar S; Das A
Comput Biol Chem; 2023 Jun; 104():107867. PubMed ID: 37030103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
